Skip to main
TRLV

TRLV Stock Forecast & Price Target

TRLV Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Trulieve Cannabis is well-positioned within the cannabis industry, holding licenses in multiple states with the potential for further expansion. Their vertically integrated model and focus on building and deepening customer relationships gives them a competitive advantage. With a dominant market position in Florida and strong growth opportunities in other states, Trulieve is poised for continued success. Risks include delayed regulatory approvals and potential changes in state-level legislation.

Bears say

Trulieve Cannabis is facing a mixed operating environment, with strong sales in its core markets of Florida, Arizona, and Pennsylvania, but potential challenges stemming from increased competition and pricing pressure. Additionally, the federal reclassification of medical-use cannabis to Schedule III could improve the industry's overall operating conditions, but Trulieve will still face a fragmented regulatory landscape with varying market sizes and profitability across states. Overall, Trulieve's established position in the U.S. cannabis market faces potential threats, causing a negative outlook for the company.

TRLV has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Trulieve Cannabis Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Trulieve Cannabis Corp (TRLV) Forecast

Analysts have given TRLV a Buy based on their latest research and market trends.

According to 1 analysts, TRLV has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Trulieve Cannabis Corp (TRLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.